TRACON Pharmaceuticals, Inc. Common Stock
TCON
TCON was delisted on the 27th of June, 2024.
33 hedge funds and large institutions have $16.4M invested in TRACON Pharmaceuticals, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
6% more funds holding
Funds holding: 31 → 33 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
17% less capital invested
Capital invested by funds: $19.7M → $16.4M (-$3.29M)
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$123K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$39.7K |
| 3 |
CL
CSS LLC
Chicago,
Illinois
|
+$38.4K |
| 4 |
Renaissance Technologies
New York
|
+$29.2K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$24.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Advisers
New York
|
-$114K |
| 2 |
Millennium Management
New York
|
-$77.9K |
| 3 |
IC
Ikarian Capital
Dallas,
Texas
|
-$44.5K |
| 4 |
Jane Street
New York
|
-$20K |
| 5 |
BFM
Boothbay Fund Management
New York
|
-$18.1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Group One Trading
Chicago,
Illinois
| $6K | – | – | – |
|
|
CG
27
Cutler Group
San Francisco,
California
| $2K | – | – | – |
|
|
TWA
28
TCI Wealth Advisors
Tucson,
Arizona
| $1K | – | – | – |
|
|
TC
29
Truvestments Capital
Sarasota,
Florida
| $1K | – | – | – |
|
30
Wells Fargo
San Francisco,
California
| $1K | – | – | – |
|
31
UBS Group
Zurich,
Switzerland
| $1K | +$1.68K | +44 | New |
|
|
MOS
32
MGO One Seven
Beachwood,
Ohio
| $19 | – | – | – |
|
|
33
Jane Street
New York
| – | -$20K | -503 | Closed |
|
34
Simplex Trading
Chicago,
Illinois
| – | -$496 | -13 | Closed |
|
35
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$38 | +1 | New |
|
TCON Hedge Fund Activity: Q3 2022 in Review
33 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in TRACON Pharmaceuticals, Inc. Common Stock (TCON) for Q3 2022, worth a combined $16.4M — down 17% from $19.7M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new TCON positions and 2 closed out — a net gain of 2 holders — while 4 added to existing stakes and 7 trimmed.
The largest buyer was Opaleye Management, adding an estimated $123K. The largest seller was Two Sigma Advisers, cutting an estimated $114K.
- 33 institutional investors held TRACON Pharmaceuticals, Inc. Common Stock (TCON) as of Q3 2022, up from 31 in Q2 2022.
- Funds reported $16.4M of TRACON Pharmaceuticals, Inc. Common Stock stock for Q3 2022, down 17% quarter-over-quarter.
- 4 funds opened new TRACON Pharmaceuticals, Inc. Common Stock positions in Q3 2022 and 2 closed out, a net change of +2 holders.
- The largest TRACON Pharmaceuticals, Inc. Common Stock buyer in Q3 2022 was Opaleye Management, an estimated $123K added.
- The largest TRACON Pharmaceuticals, Inc. Common Stock seller in Q3 2022 was Two Sigma Advisers, an estimated $114K sold.
Based on aggregated 13F filings for Q3 2022.